| Description |
ix, 182 p. : ill. |
| Series |
Business issues, competition and entrepreneurship |
|
Pharmacology-research, safety testing and regulation |
|
Business issues, competition and entrepreneurship series.
|
|
Pharmacology-research, safety testing, and regulation series.
|
| Bibliography |
Includes bibliographical references and index. |
| Contents |
Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO. |
| Reproduction |
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. |
| Subject |
Drug development.
|
|
Pharmaceutical industry.
|
|
Drugs -- Law and legislation.
|
| Genre/Form |
Electronic books.
|
| Added Author |
Mancuso, David A.
|
|
Grenada, Isobel M.
|
|
ProQuest (Firm)
|
| ISBN |
9781612093949 (hardcover) |
|
9781621004394 (electronic bk.) |
|
